Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamatergic Mechanisms in Opioid and Cocaine Co-Use
NCT05610072Phase 1Completed
- Start
- Dec 2022
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in opioid use disorder (OUD) and cocaine use disorder (CUD) comparing n-Acetylcysteine with Placebo (2 arms). Primary endpoints: Hypothetical opioid purchasing at 7 days, Hypothetical cocaine purchasing at 7 days and 2 more. Started Dec 2022; status: completed.
02
Drugs
acetylcysteine
03
Conditions
opioid use disorder (OUD)cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT05610072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05610072.